---------------------------------------------------------------------------
        UniProt Knowledgebase
        SIB Swiss Institute of Bioinformatics; Geneva, Switzerland
        European Bioinformatics Institute (EBI); Hinxton, United Kingdom
        Protein Information Resource (PIR); Washington DC, USA
---------------------------------------------------------------------------

Description: Controlled vocabulary of human diseases
Name:        humdisease.txt
Release:     2019_01 of 16-Jan-2019

---------------------------------------------------------------------------

  This document lists the controlled vocabulary that is used for the
  annotation of human diseases in UniProtKB/Swiss-Prot.

  It follows the format below:

  ---------  ---------------------------     ------------------------------
  Line code  Content                         Occurrence in an entry
  ---------  ---------------------------     ------------------------------
  ID         Identifier                      Once; starts an entry
  AC         Accession (DI-xxxxx)            Once
  AR         Acronym                         Once
  DE         Definition                      Once or more
  SY         Alternative name(s)             Optional; once or more
  DR         Cross-reference(s)              Once or more
  KW         Associated keyword (accession)  Optional; Once or more
  //         Terminator                      Once; ends an entry

  Sources: OMIM, Scientific articles, Dorland's Medical Dictionary,
  Orphanet.

___________________________________________________________________________

ID   Jackson-Weiss syndrome.
AC   DI-00602
AR   JWS.
DE   An autosomal dominant craniosynostosis syndrome characterized by
DE   craniofacial abnormalities and abnormality of the feet: broad great
DE   toes with medial deviation and tarsal-metatarsal coalescence.
SY   Craniosynostosis-midfacial hypoplasia-foot abnormalities.
DR   MIM; 123150; phenotype.
DR   MedGen; C0795998.
DR   MeSH; D003398.
DR   MeSH; D005532.
KW   KW-0989:Craniosynostosis.
//
ID   2,4-dienoyl-CoA reductase deficiency.
AC   DI-04240
AR   DECRD.
DE   A rare, autosomal recessive, inborn error of polyunsaturated fatty
DE   acids and lysine metabolism, resulting in mitochondrial dysfunction.
DE   Affected individuals have a severe encephalopathy with neurologic and
DE   metabolic abnormalities beginning in early infancy. Laboratory studies
DE   show increased C10:2 carnitine levels and hyperlysinemia.
DR   MIM; 616034; phenotype.
DR   MedGen; CN037048.
DR   MeSH; D020167.
DR   MeSH; D028361.
//
ID   2-aminoadipic 2-oxoadipic aciduria.
AC   DI-03673
AR   AMOXAD.
DE   A metabolic disorder characterized by increased levels of 2-oxoadipate
DE   and 2-hydroxyadipate in the urine, and elevated 2-aminoadipate in the
DE   plasma. Patients can have mild to severe intellectual disability,
DE   muscular hypotonia, developmental delay, ataxia, and epilepsy. Most
DE   cases are asymptomatic.
DR   MIM; 204750; phenotype.
DR   MedGen; C1859817.
DR   MeSH; D000592.
//
ID   3-alpha-hydroxyacyl-CoA dehydrogenase deficiency.
AC   DI-00002
AR   HADH deficiency.
DE   An autosomal recessive, metabolic disorder with various clinical
DE   presentations including hypoglycemia, hepatoencephalopathy, myopathy
DE   or cardiomyopathy, and in some cases sudden death.
SY   HAD deficiency.
SY   Hydroxyacyl-coenzyme A dehydrogenase deficiency.
SY   SCHAD deficiency.
DR   MIM; 231530; phenotype.
DR   MedGen; C1291230.
DR   MeSH; D008659.
//